Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

ricardouno 6 posts  |  Last Activity: Jun 11, 2016 6:58 AM Member since: Jun 5, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Also see data at ASCO on CPX-351 as comparison......bekons combo with SGN-33a ?

  • Reply to

    Follow up data on CD33 P1

    by koolbrez22 Jun 8, 2016 9:44 PM
    ricardouno ricardouno Jun 9, 2016 10:46 AM Flag

    Take a look at the CPX-351 final data set presented at ASCO. Perhaps they can add an arm to the phase3 with SGN33a that utilizes the two in combo.

  • Reply to

    Sign-33a

    by ricardouno May 25, 2016 10:18 AM
    ricardouno ricardouno May 25, 2016 12:57 PM Flag

    Atpl, thanks for that info. Looking forward to the detailed reporting at the Copenhagen conference. Ricardo

  • ricardouno by ricardouno May 25, 2016 10:18 AM Flag

    Hard to imagine that the phase 1 extended follow-up study data on SGN 33A is not "encouraging" as they are scheduled for an oral presentation in Copenhagen next month and are beginning a phase 3 registrational study as announced today .

    Patients! And good luck to all.

    Ricardo

  • Reply to

    kasich

    by rumbleinstreet Apr 4, 2016 10:57 AM
    ricardouno ricardouno Apr 5, 2016 7:09 AM Flag

    Independent here. After watching all the debates both dem and rep, Kasich seem to be the best choice. He seem to have the most public executive experience (and a near 80 per cent approval in the state he governs ) and is thoughtful and expresses solutions in a logical fashion. He does not seem to be a rigid ideologue nor a mocking bombastic egomaniac. He conveys a sincere and honest approach as is not demeaning to others. He seems to be capable of working with and bringing together people.

    Somewhat sad the media has given him the short end of the stick as he doesn't shout his speech or insult others....He just doesn't create headlines for them. Pathetically, because of that many have not heard of
    him.

  • Reply to

    SGEN opdivo

    by llabtechtwo Mar 31, 2016 10:56 PM
    ricardouno ricardouno Apr 1, 2016 8:26 PM Flag

    Atp, thanks for your referral to that very interesting video. In response to the video one of the comments by a physician was the following:

    "I have been discussing biological therapy as the future for oncology since my residency and especially during my Fellowship at Duke Cancer Center in the late 1980s. Antibody based therapy in particular has always seemed to me to have the greatest potential. With clinical studies like this ( as per Dr. Cheson ) and all the other recent findings from studies on solid tumors, it appears certain that Monoclonal Antibodies will increasingly supplant older, cytotoxic chemotherapy. Over the next 5-10 years, there will be an accelerated rise in the use of antibody treatment and a corresponding decline in the use of chemotherapy. I am reminded of what Dr Robert Oldham said to me in 1983, " Biological Therapy will become the Fourth Modality for the treatment of neoplastic diseases."

SGEN
37.59-2.48(-6.19%)Jun 24 4:00 PMEDT